Interferon regulatory factor 1 promoter polymorphism and response to type 1 interferon

Journal of Cellular Biochemistry

Volumn 81, Issue SUPPL. 36, 2001, Pages 191-200

  Saito, Hidetsugu ^a   Tada, Shinichiro ^a   Ebinuma, Hirotoshi ^a   Wakabayashi, Kanji ^a   Takagi, Tamako ^a   Saito, Yoshimasa ^a   Nakamoto, Nobuhiro ^a   Kurita, Satoshi ^a   Ishii, Hiromasa ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Interferon; IRF 1; Promoter activity; Response to IFNs; Single nucleotide polymorphism

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 1; NUCLEOTIDE; PROTEIN P21; ANTINEOPLASTIC AGENT; DNA; DNA BINDING PROTEIN; IRF1 PROTEIN, HUMAN; LUCIFERASE; PHOSPHOPROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA POLYMORPHISM; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CARCINOMA; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; CELL CULTURE; GENETICS; INTRON; MOLECULAR GENETICS; PROMOTER REGION; PROTEIN SECONDARY STRUCTURE; REPORTER GENE;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; DNA; DNA-BINDING PROTEINS; GENES, REPORTER; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE I; INTRONS; LUCIFERASES; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, SECONDARY; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035029638     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.1084     Document Type: Article

References (37)

1. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line
2. Establishment of a continuously growing cell line from primary carcinoma of the liver
3. The inducible transcriptional activator NF-κB: Regulation by distinct protein subunits
4. A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system
5. Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2
6. Establishment and some biological characteristics of human hepatoma cell lines
7. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa
8. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation
9. Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1
10. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes
11. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2
12. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation
13. Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: Implications for a gene network in the interferon system
14. A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon
15. Promoter-specific activation of RNA polymerase II transcription by Sp1
16. Interferon regulatory factor-1 is required for a T helper i immune response in vivo
17. A general approach to single-nucleotide polymorphism discovery
18. CD4+ T cells from IRF-1-deficient mice exhibit altered patterns of cytokine expression and cell subset homeostasis
19. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements
20. Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection
21. Critical role of a common transcription factor, IRF-1, in the regulation of IFN-beta and IFN-inducible genes
22. Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression
23. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression
24. Establishment of a human cell line (HCC-T) from a patient with hepatoma bearing no evidence of hepatitis B or A virus infection
25. Cloning of variable regions of an antibody that reacts with the soluble fraction of human liver cells and its possible value in chronic liver disease
26. A novel interferon-inducible domain: Structural and functional analysis of the human interferon regulatory factor i gene promoter
27. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines
28. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1
29. An IRF-1-dependent pathway of DNA damageinduced apoptosis in mitogen-activated T lymphocytes
30. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage
31. Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1
32. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration
33. Establishment of a cell line (HCC-M) from a human hepatocellular carcinoma
34. Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia
35. Interferon action-sequence specificity of the ppp(A2′p) nA-dependent ribonuclease
36. Interferon alfa receptor expression and growth inhibition by interferon alfa in human liver cancer cell lines
37. WAF1/CIP1 expression by p53-independent pathways